CXCR1 and neoplasm: Furthermore, IHC performed on tumour sections confirmed that IR exposure increased Bcl-2 in these PTEN-null tumours, which was again reversed by x1/2pal-i3-mediated inhibition of CXCR1/2 signalling (Figure 5H).